Perspective · 29 Jan 2025
Conference abstractPublished 2018
Undifferentiated adult human Mesenchymal Cells (ahMSCs) response on a novel graphene coated - nurses a phase bio-ceramic
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
It is well known that Si- Ca-P bio-ceramics are promising bioactive materials for bone tissue engineering, particularly for bone repair. Recently, it has been reported that graphene can be used as an additive to improve the properties of composites due to its biocompatibility and it has been proposed for a number of biomedical applications. Graphene has remarkable mechanical properties, which makes it potentially a good reinforcement in ceramic composites. It also has unique electrical and thermal properties, which makes it attractive filler for producing multifunctional ceramics for a wide range of applications. It has been shown that Graphene Oxide (Go) and reduced graphene oxide (r-Go) can promote biological interactions due to its many surface functional groups and serve as a carrier for drugs and other biomolecules. In addition, Go regulates the proliferation and differentiation of cultured mesenchymal stem cells. In this work, we have optimized the graphene coating of a Si-Ca-P bioceramic, obtaining scaffolds totally covered by a thin layer of graphene oxide and reduced graphene oxide. In vitro assays with adult human mesenchymal stem cells (ahMSCs) showed that A-Go stimulates cellular proliferation more than A-Gr the first days of culture. This could support the theory of other researchers that indicates that Go mainly stimulates cell proliferation, while r-Go favors cell differentiation.
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Archives of Medicine.
Perspective · 29 Jan 2025
Early-life nutrition and its impact on pediatric immune development
Commentary · 29 Jan 2025
Polypharmacy in the aging population: Risks, benefits and alternatives
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalArchives of Medicine
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Ruben Rabadan-Ros”
- BylineArticles whose byline prints “Belen Gil-Munoz”
- BylineArticles whose byline prints “Clara Meseguer-Ortiz”
- BylineArticles whose byline prints “Dra Piedad N de Aza”
- BylineArticles whose byline prints “Luis Meseguer-Olmo”
